Q: The future of Pharmacy benefit managers (PBMs) remains unclear to me even after I worked my way through financials, analysts’ comments, analytics and commentaries in the more serious financial journals. CVS and ESRX appear to have been hit hard this year by the mere possibility being whispered ---- that Amazon might enter the pharmacy markets. Amazon might well do that just as they might start their own delivery service to compete with FedEx and UPS.
But surely even mighty Amazon cannot drink ALL the water in ALL the oceans.... or can they? The latter might well be confirmation bias in my reptilian brain.
I had largish positions in CVS and in ESRX. Whereas I had previously decided to ride things out, I have now trimmed at largish losses. I have reviewed past questions here on both CVS and ESRX, including my own past questions.
1. Do you care to update your answers in view of the seemingly unstoppable powerhouse that is Amazon?
2. What would you suggest a risk-tolerant (but not completely imprudent) investor do on each of CVS and ESRX?
3. Sell all and hide under the bed? Buy AMZN with the proceeds? Just PRAY?
4. I spent many hours ploughing through detailed reports on each of CVS and ESRX. Yet I am just as undecided after these reviews as I was before. Almost all analyses that I read say that both CVS and ESRX are under valued; that each is either a buy or a strong buy. I grant that the latter could have been confirmation bias in my reptilian brain.
5. What are YOUR insightful thoughts on the PBM business model in view of (a) possible Amazon threat (with reasons if you would please)
6. Since US Gov policy changes would make significant impact on all PBMs, although you might prefer not to incorporate the current instability in US politics into your own equations, I think in this case, please if you can make an exception and incorporate the political landscape into your comments, that would be very helpful.
7. I would be thankful for your substantive response on each of CVS and ESRX separately as their businesses have significant differences.
But surely even mighty Amazon cannot drink ALL the water in ALL the oceans.... or can they? The latter might well be confirmation bias in my reptilian brain.
I had largish positions in CVS and in ESRX. Whereas I had previously decided to ride things out, I have now trimmed at largish losses. I have reviewed past questions here on both CVS and ESRX, including my own past questions.
1. Do you care to update your answers in view of the seemingly unstoppable powerhouse that is Amazon?
2. What would you suggest a risk-tolerant (but not completely imprudent) investor do on each of CVS and ESRX?
3. Sell all and hide under the bed? Buy AMZN with the proceeds? Just PRAY?
4. I spent many hours ploughing through detailed reports on each of CVS and ESRX. Yet I am just as undecided after these reviews as I was before. Almost all analyses that I read say that both CVS and ESRX are under valued; that each is either a buy or a strong buy. I grant that the latter could have been confirmation bias in my reptilian brain.
5. What are YOUR insightful thoughts on the PBM business model in view of (a) possible Amazon threat (with reasons if you would please)
6. Since US Gov policy changes would make significant impact on all PBMs, although you might prefer not to incorporate the current instability in US politics into your own equations, I think in this case, please if you can make an exception and incorporate the political landscape into your comments, that would be very helpful.
7. I would be thankful for your substantive response on each of CVS and ESRX separately as their businesses have significant differences.
